Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis-Reference-Cited by-同舟云学术

Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis

Published:2021-01 Issue:1 Volume:24 Page:101902
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Shi Bo,Wang Wenxia,Korman Benjamin,Kai Li,Wang Qianqian,Wei Jun,Bale Swarna,Marangoni Roberta Goncalves,Bhattacharyya Swati,Miller Stephen,Xu Dan,Akbarpour Mahzad,Cheresh Paul,Proccissi Daniele,Gursel Demirkan,Espindola-Netto Jair Machado,Chini Claudia C.S.,de Oliveira Guilherme C.,Gudjonsson Johann E.,Chini Eduardo N.,Varga John

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference70 articles.

1. SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis;Akamata;Oncotarget,2016

2. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38;Aksoy;Biochem. Biophys. Res. Commun.,2006

3. Regulation of intracellular levels of NAD: a novel role for CD38;Aksoy;Biochem. Biophys. Res. Commun.,2006

4. Systemic sclerosis;Allanore;Nat. Rev. Dis. Primers,2015

5. Rationally-based therapeutic disease modification in systemic sclerosis: novel strategies;Asano;Semin. Cell Dev. Biol.,2019

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirtuin3 and Sirtuin7 are promising biomarkers in systemic sclerosis;Egyptian Rheumatology and Rehabilitation;2024-07-01

2. Redox Pathogenesis in Rheumatic Diseases;ACR Open Rheumatology;2024-04-25

3. CD38 deficient mice are not protected from atherosclerosis;Biochemical and Biophysical Research Communications;2024-04

4. Emerging therapeutic targets in systemic sclerosis;Journal of Molecular Medicine;2024-02-22

5. Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy;2024-02-14